Dry Powder Formulations And Methods For Treating Pulmonary Diseases

Patent No. EP2410981 (titled "Dry Powder Formulations And Methods For Treating Pulmonary Diseases") was filed by Pulmatrix on Mar 26, 2010. The application was issued on Feb 26, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA UK	Dec 12, 2017	GILLARD
TEVA PHARMACEUTICALS	Dec 12, 2017	ELKINGTON AND FIFE
TEVA PHARMACEUTICALS	Dec 12, 2017	ELKINGTON & FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jan 30, 2020
Decision to maintain the European patent in amended form
Jan 30, 2020
Decision to maintain the European patent in amended form
Jan 24, 2020
Termination of the opposition proceedings with maintenance of patent
Jan 15, 2020
Description
Jan 15, 2020
Filing of the translation of the amended claims
Jan 15, 2020
French translation of claims
Jan 15, 2020
German translation of the claims
Nov 5, 2019
Communication of bibliographic data
Nov 5, 2019
Communication to opponent concerning maintenance
Nov 5, 2019
Communication with request to file translations
Oct 18, 2019
Maintenance of the patent with the documents specified in the final decision
Jul 1, 2019
Advice of delivery
Jun 28, 2019
Advice of delivery
Jun 26, 2019
Advice of delivery
Jun 25, 2019
Annex to the communication - opposition
Jun 25, 2019
Decision of the Opposition Division and instruction
Jun 25, 2019
Grounds for the decision (Annex) - opposition
Jun 25, 2019
Interlocutory decision in opposition proceedings
Jun 25, 2019
Internal form - Opposition/addressees
Jun 25, 2019
Internal form - Opposition/addressees
Jun 25, 2019
Means of redress
Jun 25, 2019
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Jun 25, 2019
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Jun 25, 2019
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Jun 25, 2019
OPPODREX with handwritten amendments
Jun 25, 2019
Provision of a copy of the minutes - opposition procedure
Jun 25, 2019
Scanned annex to a communication - opposition procedure
May 9, 2019
Information about the result of oral proceedings
Apr 2, 2019
Letter which had not been notified
Mar 27, 2019
Brief communication in opposition procedure - time limit
Mar 13, 2019
Brief communication - Opposition proceedings
Mar 13, 2019
Brief communication - Opposition proceedings
Mar 8, 2019
(Electronic) Receipt
Mar 8, 2019
Letter accompanying subsequently filed items
Mar 8, 2019
Non-patent literature cited during the opposition procedure
Mar 8, 2019
Non-patent literature cited during the opposition procedure
Mar 8, 2019
Non-patent literature cited during the opposition procedure
Mar 8, 2019
Written submission in preparation to/during oral proceedings
Mar 7, 2019
Amended claims with annotations
Mar 7, 2019
Amended claims with annotations
Mar 7, 2019
Amended claims with annotations
Mar 7, 2019
Amended claims with annotations
Mar 7, 2019
Amended claims with annotations
Mar 7, 2019
Amended claims with annotations
Mar 7, 2019
Claims
Mar 7, 2019
Claims
Mar 7, 2019
Claims
Mar 7, 2019
Claims
Mar 7, 2019
Claims
Mar 7, 2019
Claims
Mar 7, 2019
Written submission in preparation to/during oral proceedings
Feb 15, 2019
Brief communication - Opposition proceedings
Feb 11, 2019
(Electronic) Receipt
Feb 11, 2019
Letter accompanying subsequently filed items
Feb 11, 2019
Request for interpreters during oral proceedings
Oct 2, 2018
Request for change of opponent's representative
Oct 1, 2018
Advice of delivery
Sep 17, 2018
Advice of delivery
Sep 14, 2018
Advice of delivery
Sep 12, 2018
Advice of delivery
Sep 11, 2018
Annex to the communication - opposition
Sep 11, 2018
Summons to attend oral proceedings
Sep 11, 2018
Summons to attend oral proceedings
Sep 7, 2018
Notification concerning the date of oral proceedings
Sep 6, 2018
Brief communication - Opposition proceedings
Aug 31, 2018
Oral proceedings: Request for postponement
Aug 28, 2018
Brief communication - Opposition proceedings
Aug 22, 2018
(Electronic) Receipt
Aug 22, 2018
Any annexes (other than citation) to an opposition letter
Aug 22, 2018
Letter accompanying subsequently filed items
Aug 22, 2018
Oral proceedings: Request for postponement
Aug 15, 2018
Advice of delivery
Aug 8, 2018
Advice of delivery
Aug 7, 2018
Annex to the communication - opposition
Aug 7, 2018
Information concerning oral proceedings
Aug 7, 2018
Preparation for oral proceedings
Aug 7, 2018
Summons to attend oral proceedings
Aug 7, 2018
Summons to attend oral proceedings
Jul 19, 2018
Brief communication - Opposition proceedings
Jul 16, 2018
(Electronic) Receipt
Jul 16, 2018
Letter accompanying subsequently filed items
Jul 16, 2018
Letter regarding the opposition procedure (no time limit)
Jun 26, 2018
Brief communication - Opposition proceedings
Jun 19, 2018
Letter regarding the opposition procedure (no time limit)
May 3, 2018
Brief communication - Opposition proceedings
Apr 27, 2018
(Electronic) Receipt
Apr 27, 2018
Letter accompanying subsequently filed items
Apr 27, 2018
Letter regarding the opposition procedure (no time limit)
Apr 27, 2018
Patent document cited during the opposition procedure
Mar 22, 2018
Brief communication - Opposition proceedings
Mar 15, 2018
Any annexes (other than citation) to an opposition letter
Mar 15, 2018
Any annexes (other than citation) to an opposition letter
Mar 15, 2018
Non-patent literature cited during the opposition procedure
Mar 15, 2018
Reply of the patent proprietor to the notice(s) of opposition
Jan 8, 2018
Communication of a notice of opposition and request to file observations
Jan 8, 2018
Notice of further oppositions to opponent(s)
Dec 18, 2017
Communication of a notice of opposition - first information to patent proprietor
Dec 12, 2017
(Electronic) Receipt
Dec 12, 2017
Notice of opposition
Dec 12, 2017
Notice of opposition
Dec 12, 2017
Notice of opposition
May 4, 2017
Communication of the registration of a transfer or change of name and/or address
Apr 11, 2017
Annexes in respect of a client data request
Apr 11, 2017
Submission concerning change of applicant's name
Mar 22, 2017
Refund of fees
Mar 15, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 16, 2017
Decision to grant a European patent
Jan 26, 2017
Payment of fees and costs
Jan 20, 2017
Filing of the translations of the claims
Jan 20, 2017
French translation of claims
Jan 20, 2017
German translation of the claims
Sep 30, 2016
Bibliographic data of the European patent application
Sep 30, 2016
Communication about intention to grant a European patent
Sep 30, 2016
Intention to grant (signatures)
Sep 30, 2016
Text intended for grant (clean copy)
Sep 30, 2016
Text intended for grant (version for approval)
Aug 16, 2016
Amended description with annotations
Aug 16, 2016
Description
Aug 16, 2016
Reply to communication from the Examining Division
Apr 21, 2016
Annex to the communication
Apr 21, 2016
Communication from the Examining Division
Jul 6, 2015
Amended claims with annotations
Jul 6, 2015
Claims
Jul 6, 2015
Reply to communication from the Examining Division
Mar 10, 2015
Annex to the communication
Mar 10, 2015
Communication from the Examining Division
Mar 3, 2015
Examination started
Feb 11, 2015
Enquiry as to when a communication from the Examining Division can be expected
Jan 12, 2015
Enquiry as to when a communication from the Examining Division can be expected
Jul 3, 2014
Response to enquiry for communication from the Examining Division
Jun 26, 2014
Enquiry as to when a communication from the Examining Division can be expected
Feb 4, 2014
Submission concerning representation
Dec 13, 2013
Submission concerning representation
May 15, 2012
Amended claims filed after receipt of (European) search report
May 15, 2012
Amended claims with annotations
May 15, 2012
Amendments received before examination
Jan 4, 2012
Notification on forthcoming publication of bibliographic data
Nov 17, 2011
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Oct 25, 2011
Amended claims filed after receipt of (European) search report
Oct 25, 2011
Amendments received before examination
Oct 25, 2011
Request for entry into the European phase
Oct 11, 2011
Copy of the international preliminary report on patentability
Aug 3, 2011
Information on entry into European phase
Feb 3, 2011
Copy of the international search report
Feb 3, 2011
International publication of the international search report
Dec 16, 2010
Written opinion of the ISA, boxes No. I to VIII
Dec 16, 2010
Written opinion of the ISA, cover sheet
Dec 16, 2010
Written opinion of the ISA, supplemental box
Oct 19, 2010
Priority document (electronically transmitted)
Oct 19, 2010
Priority document (electronically transmitted)
Oct 19, 2010
Priority document (electronically transmitted)
Oct 19, 2010
Priority document (electronically transmitted)
Oct 19, 2010
Priority document (electronically transmitted)
Oct 19, 2010
Priority document (electronically transmitted)
Oct 19, 2010
Priority document (electronically transmitted)
Sep 30, 2010
Published international application - A2
Jun 16, 2010
Drawings
May 27, 2010
Request for correction of obvious error
May 27, 2010
Request for correction of obvious error
May 27, 2010
Request for correction of obvious error
Apr 21, 2010
Abstract
Apr 21, 2010
Claims
Apr 21, 2010
Description
Apr 21, 2010
Drawings

EP2410981

PULMATRIX

Application Number: EP10713283A
Filing Date: Mar 26, 2010
Status: Patent Maintained As Amended; Jan 24, 2020
Publication Date: Feb 26, 2020
External Links: Slate, Register , Google Patents

IP Verse

Dry Powder Formulations And Methods For Treating Pulmonary Diseases

Patent Summary

Patent Family

Patent Oppositions (3)

Dossier Documents

EP2410981